欧洲干细胞治疗市场预测至 2028 年 - COVID-19 影响和区域分析（按类型（成人干细胞治疗、胚胎干细胞治疗、诱导多能干细胞治疗和其他干细胞治疗）、治疗（同种异体和自体）、应用（肌肉骨骼、皮肤科、心脏病学、药物发现和开发以及其他应用）和最终用户（医院和专科诊所以及学术和研究机构）
No. of Pages: 144 | Report Code: BMIRE00028473 | Category: Life Sciences
No. of Pages: 144 | Report Code: BMIRE00028473 | Category: Life Sciences
癌症是全世界死亡的主要原因之一，该疾病深刻影响着生活质量。美国国家癌症研究所的报告还指出，干细胞移植有助于恢复接受化疗或放疗的癌症患者的造血细胞。造血干细胞很重要，因为它们促进不同类型血细胞的生长，例如白细胞 (WBC)、红细胞 (RBC) 和血小板。干细胞移植并不直接对抗癌症；相反，它们有助于在接受高剂量放疗、化疗或两者治疗后恢复身体产生干细胞的能力。因此，对先进癌症治疗需求的增加正在推动欧洲干细胞治疗市场的增长。
欧洲干细胞治疗市场分为德国、英国、法国、意大利和西班牙。由于慢性病患病率不断上升、干细胞疗法意识不断增强以及广泛的研究和应用，德国和英国等国家预计将成为干细胞疗法市场的最大贡献者。发展活动。此外，南欧快速发展的医疗基础设施预计将为欧洲干细胞治疗市场提供利润丰厚的增长机会。
德国的主要参与者和卫生组织都参与研发开发用于治疗一系列疾病的干细胞疗法的活动。例如，2018年7月，市场领先的干细胞疗法参与者之一Viscofan BioEngineering宣布西班牙药品管理局（AEMPS）批准其再生医学临床I期试验。这种新疗法将旨在治疗患有严重心功能不全的患者。此外，该国对干细胞疗法益处的认识正在不断提高。许多研究机构正在相互合作，旨在开发一系列针对慢性病的新疗法。例如，2018年10月，弗劳恩霍夫研究所宣布与日本再生医学会合作。两人同意开发新的再生药物，包括治疗疾病的干细胞疗法。此外，这些组织还签署了一份谅解备忘录，以相互分享研究信息、技术和监管发展。
欧洲干细胞治疗市场分为类型、治疗、应用、最终用户和国家。
欧洲干细胞治疗市场按类型分为成体干细胞治疗、诱导多能干细胞治疗、胚胎干细胞治疗和其他干细胞治疗。成体干细胞治疗领域在 2022 年占据最大的市场份额。
根据治疗，欧洲干细胞治疗市场分为同种异体和自体干细胞治疗。到2022年，同种异体干细胞治疗市场占据最大份额。
根据应用，欧洲干细胞治疗市场分为肌肉骨骼、皮肤病学、心脏病学、药物发现和开发、其他应用程序。到 2022 年，肌肉骨骼领域将占据最大的市场份额。
欧洲干细胞治疗市场按最终用户划分，分为学术和干细胞治疗。研究机构和医院诊所。学术与研究机构细分市场在 2022 年占据最大份额。
根据国家/地区，欧洲干细胞治疗市场分为德国、英国、法国、意大利、西班牙，以及欧洲其他地区。德国在 2022 年占据市场主导地位。
MEDIPOST； BioTime公司；中胚层有限公司； TiGenix NV； Holostem Terapie Avanzate Srl；和 NuVasive Inc 是欧洲干细胞治疗市场的领先公司。
Strategic insights for Europe Stem Cell Therapy involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2022 | US$ 446.75 Million |
| Market Size by 2028 | US$ 1,209.01 Million |
| Global CAGR (2022 - 2028) | 18.0% |
| Historical Data | 2020-2021 |
| Forecast period | 2023-2028 |
| Segments Covered |
By 类型
|
| Regions and Countries Covered | 欧洲
|
| Market leaders and key company profiles |
The regional scope of Europe Stem Cell Therapy refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The Europe Stem Cell Therapy Market is valued at US$ 446.75 Million in 2022, it is projected to reach US$ 1,209.01 Million by 2028.
As per our report Europe Stem Cell Therapy Market, the market size is valued at US$ 446.75 Million in 2022, projecting it to reach US$ 1,209.01 Million by 2028. This translates to a CAGR of approximately 18.0% during the forecast period.
The Europe Stem Cell Therapy Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Stem Cell Therapy Market report:
The Europe Stem Cell Therapy Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe Stem Cell Therapy Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe Stem Cell Therapy Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Europe Stem Cell Therapy Market
